Resveratrol Alleviates Inflammatory Responses and Oxidative Stress in Rat Kidney Ischemia-Reperfusion Injury and H2O2-Induced NRK-52E Cells via the Nrf2/TLR4/NF-κB Pathway

被引:106
|
作者
Li, Jiawei [1 ,2 ]
Li, Long [1 ,2 ]
Wang, Shuo [1 ,2 ]
Zhang, Chao [1 ,2 ]
Zheng, Long [1 ,2 ]
Jia, Yichen [1 ,2 ]
Xu, Ming [1 ,2 ]
Zhu, Tongyu [1 ,2 ]
Zhang, Yi [2 ,3 ]
Rong, Ruiming [1 ,2 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Urol, 180 Fenglin Rd, Shanghai 200032, Peoples R China
[2] Shanghai Key Lab Organ Transplantat, Shanghai, Peoples R China
[3] Fudan Univ, Inst Clin Sci, Zhongshan Hosp, Biomed Res Ctr, Shanghai, Peoples R China
关键词
Resveratrol; Ischemia-reperfusion injury; Kidney; Inflammation; Oxidative stress; TOLL-LIKE RECEPTORS; NF-KAPPA-B; ISCHEMIA/REPERFUSION INJURY; RENAL GRAFT; PREVENTION; PROTECTS; DAMAGE; NRF2; ACTIVATION; INHIBITION;
D O I
10.1159/000487735
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Ischemia-reperfusion injury (IRI) is one of the major causes of postoperative renal allograft dysfunction, which is mainly the result of proinflammatory reactions including inflammatory responses, oxidative stress, and metabolic disorders. Resveratrol (RSV) plays an important role in protecting various organs in IRI because it reduces oxidative stress, lessens the inflammatory response, and exerts anti-apoptotic effects. The aim of this study was to demonstrate the renoprotective effect of RSV in inhibiting inflammatory responses, reducing oxidative stress, and decreasing cell apoptosis in vivo and in vitro. Methods: RSV was administered before renal ischemia and H2O2 induction. Serum and kidneys were harvested 24 h after reperfusion and NRK-52E cells were collected 4 h after H2O2 stimulation. Serum creatinine and blood urea nitrogen were used to assess renal function. Hematoxylin and eosin staining was performed to assess histological injury. Quantitative real-time PCR and enzyme linked immunosorbent assay were used to assess proinflammatory cytokine expression. Oxidative stress related proteins, such as Nrf2 and TLR4, were evaluated by western blot. Terminal deoxynucleotidyl transferase mediated dUTP-biotin nick end labeling assay was used to detect apoptotic cells in tissues, and western blot was used to evaluate the expression of caspase-3,-8, and-9 in this study. Results: RSV inhibited inflammatory responses and improved renal function after renal IRI. Additionally, RSV decreased oxidative stress and reduced cell apoptosis by upregulating Nrf2 expression, downregulating the TLR4/NF-kappa B signaling pathway, and by decreasing caspase-3 activity and caspase cascades. Conclusion: Our study demonstrated the mechanisms underlying RSV renoprotection. We found that RSV exerts its greatest effects by blocking inflammatory responses, lowering oxidative stress, and reducing apoptosis via the Nrf2/TLR4/NF-kappa B pathway. (C) 2018 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:1677 / 1689
页数:13
相关论文
共 50 条
  • [1] RESVERATROL ALLEVIATES INFLAMMATORY RESPONSES AND OXIDATIVE STRESS IN RAT KIDNEY IRI AND H2O2-INDUCED NRK-52E CELLS VIA NRF2/TLR4/NF-κB PATHWAY
    Zhang, Yi
    Li, Jiawei
    Li, Long
    Rong, Ruiming
    TRANSPLANT INTERNATIONAL, 2017, 30 : 574 - 574
  • [2] Luteolin alleviates ochratoxin A induced oxidative stress by regulating Nrf2 and HIF-1α pathways in NRK-52E rat kidney cells
    Liu, Man
    Cheng, Chao
    Li, Xuezhi
    Zhou, Sihan
    Hua, Jiali
    Huang, Jie
    Li, Yongxin
    Yang, Kunlong
    Zhang, Peng
    Zhang, Yan
    Tian, Jun
    FOOD AND CHEMICAL TOXICOLOGY, 2020, 141
  • [3] Resveratrol attenuates inflammation and oxidative stress induced by myocardial ischemia-reperfusion injury: role of Nrf2/ARE pathway
    Cheng, Liang
    Jin, Zhenxiao
    Zhao, Rong
    Ren, Kai
    Deng, Chao
    Yu, Shiqiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (07): : 10420 - 10428
  • [4] Lupeol Alleviates Myocardial Ischemia-Reperfusion Injury in Rats by Regulating NF-κB and Nrf2 Pathways
    Li, Jing
    Ma, Xuming
    Yang, Jun
    Wang, Luzhen
    Huang, Yan
    Zhu, Yan
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2022, 50 (05): : 1269 - 1280
  • [5] Umbelliferone alleviates hepatic ischemia/reperfusion-induced oxidative stress injury via targeting Keap-1/Nrf-2/ARE and TLR4/NF-κB-p65 signaling pathway
    Hassanein, Emad H. M.
    Khader, Heba F.
    Elmansy, Rasha A.
    Seleem, Hanan S.
    Elfiky, Mohamed
    Mohammedsaleh, Zuhair M.
    Ali, Fares E. M.
    Abd-Elhamid, Tarek Hamdy
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2021, 28 (47) : 67863 - 67879
  • [6] Umbelliferone alleviates hepatic ischemia/reperfusion-induced oxidative stress injury via targeting Keap-1/Nrf-2/ARE and TLR4/NF-κB-p65 signaling pathway
    Emad H. M. Hassanein
    Heba F. Khader
    Rasha A. Elmansy
    Hanan S. Seleem
    Mohamed Elfiky
    Zuhair M. Mohammedsaleh
    Fares E. M. Ali
    Tarek Hamdy Abd-Elhamid
    Environmental Science and Pollution Research, 2021, 28 : 67863 - 67879
  • [7] Maresin 1 mitigates renal ischemia/reperfusion injury in mice via inhibition of the TLR4/MAPK/NF-κB pathways and activation of the Nrf2 pathway
    Qiu, Yun
    Wu, Yichen
    Zhao, Hongmei
    Sun, Hong
    Gao, Sumin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 739 - 745
  • [8] Solasonine ameliorates cerebral ischemia-reperfusion injury via suppressing TLR4/MyD88/NF-κB pathway and activating AMPK/Nrf2/HO-1 pathway
    Huo, Kang
    Xu, Jing
    Wei, Meng
    Ma, Kaige
    Wang, Jianyi
    Han, Jianfeng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124
  • [9] Effects of dexmedetomidine on the degree of myocardial ischemia-reperfusion injury, oxidative stress and TLR4/NF-κB signaling pathway in rats
    Liu, Yu
    Qu, Xiaolong
    Zhang, Jinhui
    Wang, Xue
    Wang, Jianying
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 34 (05) : 2047 - 2051
  • [10] Sivelestat Sodium Alleviates Ischemia-Reperfusion -Induced Acute Kidney Injury via Suppressing TLR4/Myd88/NF-κB Signaling Pathway in Mice
    Wang, Jie
    Wu, Yuanbo
    Mao, Meng
    Bing, Hailong
    Sun, Liwei
    Xu, Wei
    Tian, Wangli
    Xia, Zhengyuan
    Jin, Xiaogao
    Chu, Qinjun
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 4449 - 4458